gip and glp 1 drugs Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Frontiers | Clinical perspectives on
Description
1 It also continues to be one of the most common comorbidities of obesity with nearly half of new T2D cases being reported in patients with obesity
Yao, Y., Xu, X
El Eid L, Reynolds CA, Tomas A, et al
doi: 10.1056/NEJMoa2032183 20 FoxCKAuerbachPBarrientos-PrezMGiesIHalePMMarcusCet al
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
